2015•Journal of the American College of SurgeonsRequires access

Post-treatment neutrophil-to-lymphocyte ratio (NLR) is an independent prognostic marker in patients with localized pancreatic cancer treated with neoadjuvant therapy

Sophia Rokkas, Kathleen K. Christians, Mohammed Aldakkak, Ben George, Paul S. Ritch, Bradley A. Erickson, Fabian Mc. Johnston, Douglas B. Evans, Susan Tsai

Open publisher page 0 citations

Abstract

Rokkas, Sophia; Christians, Kathleen K. MD, FACS; Aldakkak, Mohammed MD; George, Ben MD; Ritch, Paul S. MD; Erickson, Beth A. MD; Johnston, Fabian M. MD; Evans, Douglas B. MD, FACS; Tsai, Susan MD, MHS Author Information

About this research paper

What this paper is about

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Medicine, George (robot), Neutrophil to lymphocyte ratio, Pancreatic cancer, Internal medicine, Cancer, Lymphocyte, Oncology